A Single-Institution Retrospective Series of SARS-CoV-2 Infection in Adult Glioma Patients.

ABSTRACT: A subset of cancer patients is particularly vulnerable to SARS-CoV-2 infection; however, real-world outcomes-based data on primary central nervous system tumor patients is sparse. This retrospective series describes a cohort of adult glioma patients seen at Stanford Cancer Center between January 1, 2020, and June 30, 2022 who contracted SARS-CoV-2, which, to our knowledge, currently represents the largest single-institution comprehensive analysis of this patient population. We performed a retrospective search of patients seen in the Stanford Neuro-Oncology clinic, identifying 29 cases of COVID-19 amongst glioma patients and extracted clinical data via individual chart review. At the time of COVID-19 diagnosis, 15 patients had been vaccinated against SARS-CoV-2, 8 patients were taking dexam

SUBMITTER: Lanman T 

PROVIDER: S-EPMC10601729 | biostudies-literature | 2023 Jan-Dec

REPOSITORIES: biostudies-literature